Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.8T | 14.7T | 14.0T | 14.7T |
Cost of revenue | 12.7T | 12.4T | 11.7T | 12.8T |
Gross profit | 2.1T | 2.3T | 2.3T | 1.8T |
Operating expense | ||||
Research & development | — | 462.1B | 504.7B | 422.1B |
Selling general and admin | 1.3T | 488.9B | 448.5B | 415.3B |
Other operating expenses | — | — | — | — |
Operating income | 2.1T | 986.4B | 908.6B | 636.1B |
Non operating interest income | ||||
Income | — | 113.5B | 111.2B | 104.9B |
Expense | — | 36.4B | 31.8B | 31.1B |
Other income expense | — | — | — | — |
Pretax income | 1.5T | 1.3T | 1.3T | 1.4T |
Tax provision | 439.4B | 44.1B | 385.4B | 414.6B |
Net income | 1.0T | 1.3T | 921.2B | 997.7B |
Basic EPS | 11.4K | — | 10.2K | 11.1K |
Diluted EPS | 11.4K | — | 10.2K | 11.1K |
Basic average shares | — | — | 90.0M | 90.0M |
Diluted average shares | — | — | 90.0M | 90.0M |
EBITDA | 2.1T | 1.7T | 1.6T | 1.7T |
Net income from continuing op. | — | 1.3T | 921.2B | 997.7B |
Minority interests | -746M | -304M | -1.6B | -1.4B |
Preferred stock dividends | — | — | — | — |